Загрузка...
New Oral Anticoagulants for Atrial Fibrillation: Are They Worth the Risk?
Atrial fibrillation (AF) is the most common cardiac arrhythmia in the U.S. Anticoagulation is recommended for stroke prevention in AF patients with intermediate-to-high stroke risk (i.e., patients with a CHADS(2) score of 1 or greater). Warfarin was previously the only option for oral anticoagulatio...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MediMedia USA, Inc.
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3956385/ https://ncbi.nlm.nih.gov/pubmed/24672216 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|